This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Fundacion Articular, Inis Biotech LLC. Active years: 2019.
Company Filing History:
1 out of 81 
1 out of 1 
1 out of 20 
Years Active: 2019
Title: Alejandra Carrea: Pioneering Innovation in Biotechnology
Introduction
Alejandra Carrea is an esteemed inventor based in Provincia de Buenos Aires, Argentina. With a notable patent to her name, she has made significant contributions to the field of biotechnology, particularly in understanding the mechanisms of cell signaling.
Latest Patents
Alejandra holds a patent for an isoform of the TGF-beta receptor II. This innovative isoform comprises a sequence of approximately 80 amino acids and notably lacks a transmembrane domain. It functions as a TGF-β1 agonist and includes the amino acid sequence outlined in SEQ ID No. 12. Additionally, this isoform may also possess the amino acid sequence specified in SEQ ID No. 2, or related sequences that maintain at least 85% sequence identity to it. Her work on this patent highlights her expertise in molecular biology and cellular signaling pathways.
Career Highlights
Throughout her career, Alejandra has been associated with leading organizations in scientific research. She has worked at the National Scientific and Technical Research Council (CONICET) and the Articular Foundation. Her positions in these institutions have allowed her to collaborate on groundbreaking research aimed at advancing medical and biotechnology applications.
Collaborations
In her journey, Alejandra has collaborated with notable professionals, including Ricardo Alfredo Dewey and Benito Jorge Velasco Zamora. These collaborations have fostered a vibrant exchange of ideas, leading to innovative research developments.
Conclusion
Alejandra Carrea's contributions to biotechnology, highlighted by her patent and collaborative work, underscore her role as a leading inventor in her field. Her dedication to advancing scientific knowledge continues to inspire future innovations in biotechnology and beyond.